BUPE2024.COMBUPE2024.COM
  • Home
  • Presentations
  • Posters
  • Info
    • ——————————
      • Call For Presentations, Posters, etc
      • CME/CPE Information
        • Conference Chairs
    • ——————————
      • Contact Us
      • Speakers
    • ——————————
      • Conference Information
      • Terms and conditions
      • Tickets
    • ——————————
      • Educational Support
      • Sponsorship & Exhibits
  • Register Now to Watch
  • Login
  • Get Started Now!
  • Home
  • Presentations
  • Posters
  • Info
    • ——————————
      • Call For Presentations, Posters, etc
      • CME/CPE Information
        • Conference Chairs
    • ——————————
      • Contact Us
      • Speakers
    • ——————————
      • Conference Information
      • Terms and conditions
      • Tickets
    • ——————————
      • Educational Support
      • Sponsorship & Exhibits
  • Register Now to Watch
  • Login
  • Get Started Now!

Major

10/262021

Gurpreet Singh Guliani, MD, MBBS

Gurpreet Singh Guliani received M.D Degree in Psychiatry  from Govt Medical school and hospital in Amritsar, Punjab, India. After postgraduation he worked as a consultant psychiatrist at different locations in India. He is currently working as a Fellow in Addiction Psychiatry for the past year at University of Kansas School of Medicine, Kansas. His professional interests focus on psychopharmacology, addiction psychiatry and research work in psychiatry. His current projects include retrospective study on buprenorphine to find the mean and effective dosage in elderly. In addition he is interested in teaching medical students and is a member of numerous professional associations in US and abroad. He will looking to complete general psychiatry residency training in USA and continuing his career in united states.

Gurpreet Singh Guliani, MD, MBBS, Department of Psychiatry and Behavioral Sciences, University of Kansas Health System, Kansas City, Kansas.

Read more
09/172021

Andrea Rubinstein, MD

Andrea Rubinstein, MD

Dr. Rubinstein is an anesthesiologist who specializes in chronic pain. Prior to medical school, she worked as a software engineer and has a special love for ‘solving problems’ and she uses an individualized problem-solving approach in all her clinical work.

Dr. Rubinstein attended Stanford University Medical School and completed her residency in anesthesiology at Duke University. While at Stanford, she became fascinated with pain and acutely aware of medicines’ limitations when it comes to solving many of the problems associated with pain.

She joined Kaiser Permanente in 2007 and served as chief of the department of pain medicine in Santa Rosa, California. She sees her role as helping patients find creative solutions to difficult pain syndromes. To do this work, she uses a multidisciplinary, bio-psycho-social approach, optimizing physical reconditioning and therapy, medications, blocks, and injections.

Dr. Rubinstein divides her time between clinical work, research in the area of opioid risk, and teaching and speaking about opioid pharmacology and novel ways to approach thinking about and treating pain.

Read more
09/172021

Jeffrey Bettinger, PharmD

 

 

 

 

 

 

 

 

Jeffrey Bettinger, PharmD, Pain Management Clinical Pharmacist

Dr. Jeffrey J. Bettinger, PharmD, is a Pain Management Clinical Pharmacist with Saratoga Hospital Medical Group in Saratoga, NY, and the Senior Strategy Consultant and Therapeutics Associate for Remitigate, LLC. He also recently served as an invited expert panel member for the FDA during their public workshop Morphine Milligram Equivalents: Current Applications and Knowledge Gaps, Research Opportunities, and Future Directions. He earned his PharmD from Albany College of Pharmacy and Health Sciences in 2017 with a concentration in nephrology. Following his doctoral training, he completed a PGY1 general practice residency at the Stratton VA Medical Center in Albany, NY. Immediately following his general practice residency, he trained with Drs. Jeff Fudin and Erica Wegrzyn and completed a PGY2 Pain and Palliative Care residency at the same institution.

Dr. Bettinger’s current position with Saratoga Hospital Medical Group involves working alongside primary care providers in ten different primary care clinics, where he specializes in complex and high-risk pain medication management through direct patient care and electronic consult services. He remains fortified in academia as he continues publishing in peer-reviewed journals, presenting at regional and national meetings, and teaching various pain courses at Albany College of Pharmacy and Health Sciences. He also mentors students and residents at his clinical sites of practice.

Read more
09/172021

Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN, FAANP

Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN, FAANP

Kathleen Broglio is an Associate Professor of Medicine at Geisel School of Medicine at Dartmouth College and  Nurse Practitioner in Palliative Medicine, atDartmouth Hitchcock Medical Center.  Her studies have included:  prevalence of opioid risk in oncology; cannabis use in palliative medicine; implementation of opioid management guidelines in palliative care; and interprofessional education in palliative and hospice. Kathleen’s clinical care focuses on complex pain management and treatment of substance use disorder in patients with serious illness.  She mentors colleagues locally, regionally, and nationally on the treatment of pain in the setting of risks for substance use disorder. Her experience includes acute and chronic pain management; and acute, ambulatory, and home-based palliative care. She completed her Doctorate in Nursing Practice at New York University, a Palliative Care Fellowship at Beth Israel Medical Center, NY, a Masters in Nursing at University of Washington, Seattle, a Bachelors in Nursing at University of Hawaii and a Bachelors in Economics at University of Maryland.

Read more
09/172021

Katrina Nickels, MD

Katrina Sandoval Nickels, MD
Addiction Medicine Fellow Physician
University of Kentucky

Katrina Nickels, MD, is an Addiction Medicine Fellow at the University of Kentucky Department of Psychiatry in Lexington. She trained at the University of Kentucky College of Medicine and Internal Medicine residency program and obtained her hospice and palliative board certification through the practice pathway. She has over a decade experience at Bluegrass Care Navigators as an Associate Hospice Medical Director, a community-based palliative physician in clinic, home and nursing home settings, and as an inpatient palliative care consultant in community and tertiary care settings.  She was active in Opioid Stewardship and Pain Management Committees at the state and hospital-based healthcare organization levels.  She currently serves as an officer in the KY Chapter of the American Society of Addiction Medicine.  Her clinical interests are in the intersection of palliative care with chronic pain management and addiction medicine.  She has presented at various KY state level conferences on opioid safety in pain and palliative care, as well as at national conferences on the collaboration of palliative and addiction medicine.  She initiated a multi-institutional multi-specialty telementoring educational collaborative with a regular journal club and case discussion to support clinicians in the management of patients with serious illness, complex pain, and substance use.

 

Read more
09/172021

David Gaffney, LMSW, BCDCH

David Gaffney, LMSW, BCDCH, EFT-Adv, co-presenter

David Gaffney, LMSW, BCDCH, EFT-Adv graduated with a Bachelor’s degree from Hope College and a Master’s Degree in Social Work from the University of Michigan. He completed his externship in Systemic Family Therapy from the University of Calgary Medical School. Dave is additionally a Board Certified Diplomate in Clinical Hypnosis and exam-certified as an advanced Emotional Freedom Technique (EFT) practitioner. Dave has 30+ years of clinical social work experience, serving in positions ranging from line staff to Director of Behavioral Health. He currently works as Clinical Social Worker at the Aleda E Lutz VAMC in Saginaw, Michigan, providing psychotherapy, hypnotherapy, biofeedback and mindful meditation training in the Integrated Pain Clinic. He additionally leads the Saginaw Opioid Safety Initiative Panel. David is also the Director of Training at D. K. Associates, a Midwest-based behavioral healthcare training organization, where he also holds his private clinical practice. He has served on the board for the MidWest Society of Behavioral Medicine and Biofeedback. David currently serves as national VA Subject Matter Expert for Hypnosis, Biofeedback and Guided Imagery. He also serves as a VA mentor/trainer for CBT-Chronic Pain. He currently works with the VHA Office of Patient Centered Care & Cultural Transformation Integrated Health Coordination Center as the National Champion for Clinical Hypnosis and Guided Imagery.

Read more
09/172021

John Hopper, MD, DFASAM, FACP, FAAP

John Hopper, MD, DFASAM, FAAP, FACP, co-presenter

John Hopper, MD, DFASAM, FAAP, FACP graduated from the Wayne State University School of Medicine and completed residency in Combined Internal Medicine and Pediatrics at the University of North Carolina, where he served as Co-Chief Resident in Pediatrics. He is triple board certified in Addiction Medicine, Internal Medicine, and Pediatrics. From 1994 to 2005 he served on the faculty at Wayne State, and was medical director for psychiatry’s Research Division on Substance Abuse. From 2005 to 2008, Dr. Hopper served as Chief Medical Officer at Brighton Hospital in Brighton, Michigan. Dr. Hopper directed the Internal Medicine Residency and Addiction Medicine Fellowship at St. Joseph Mercy Hospital Ann Arbor from 2008 to 2015. From 2015 to 2020, Dr. Hopper was a Field Representative for the Clinical Learning Environment Review of the Accreditation Council on Graduate Medical Education. He is clinically active in both internal medicine and addiction medicine through Integrated Health Associates (IHA) where his is the current Associate Program Director for the Fellowship in Addiction Medicine at Saint Joe’s Ann Arbor and Director of the Chemical Dependency Unit at Saint Mary Mercy Livonia.

Read more
09/172021

Juliette Perzhinsky, MD, MSc, FACP

Juliette Perzhinsky, MD, MSc, FACP, moderator/lead presenter

Juliette Perzhinsky, MD, MSc, FACP is a board-certified general internal medicine and board-eligible addiction medicine physician with experience in implementing curricular changes across the continuum of medical training at Central Michigan University (CMU) College of Medicine, in collaboration with other health professions training programs. She is a graduate of Wayne State University School of Medicine and completed an Internal Medicine Residency at the University of Pittsburgh Medical Center. From 2015-2018, she served as an Associate Program Director of the CMU Internal Medicine Residency Training Program in Saginaw, MI and was charged with initiatives pertaining to patient safety and helping resident physicians increase self-efficacy with chronic pain management. She was previously selected as a Gold Humanism Scholar and was also the recipient of a Picker Gold GME Challenge Grant through The Arnold P Gold Foundation, leading important curricular changes in medical education. In her clinical practice, Dr. Perzhinsky has been delivering medication for addiction treatment (MAT) to patients with opioid use disorder after receiving the DEA X waiver to prescribe buprenorphine in 2019 and manages patients with complex chronic pain. Recently, she implemented a new integrative treatment program at the Ann Arbor VA Healthcare System – Flint Community-Based Outpatient Clinic – offering acupuncture and mindfulness meditation as part of an integrated chronic pain and MAT clinic model. She additionally invites third year medical students for clinical observation experiences during their MAT community experiences in mid-Michigan. She serves as the Project Director and co-instructor of the Drug Addiction Treatment Act (DATA) MAT waiver training to students and faculty at CMU as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) grant.

Read more
09/172021

Andrea Jakubowski, MD, MS

Andrea Jakubowski, MD, MS, Assistant Professor of Medicine, Department of Internal Medicine, Division of General Internal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
ORCID: https://orcid.org/0000-0001-5651-5589.

Read more
09/172021

Aaron D. Fox, MD, MS

Aaron D. Fox, MD, MS, Associate Professor of Medicine, Department of Internal Medicine, Division of General Internal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.

Read more
Older Entries
Newer Entries
Search
Latest Presentations
  • Buprenorphine: Not Just Another Opioid – Understanding the World’s Most Interesting Opioid
  • Impact of an Education Module on the Knowledge and Attitudes of EM Physicians Towards Prescribing Buprenorphine / Naloxone for Opioid Use Disorder
  • Buprenorphine for Cancer Pain: Results from a Systematic Review
  • Buprenorphine: Opioid Agonist-Antagonist Benefits for Opioid Resistant Pain Uncontrolled By Full-Agonist Opioids during Hematopoietic Stem Cell Transplant for Sickle Cell Disease
Categories
  • Posters
  • Presentations
  • Presentations for CME Review

Journal of Opioid Management (JOM) has assembled the best and brightest minds in opioid analgesics who will explore the benefits and challenges of using buprenorphine to treat patients across the spectrum.

BUPE2024/2025 is presented by the Journal of Opioid Management. We are dedicated to presenting the latest research and practice for managing patients on opioid therapies.

INFORMATION
  • Terms and conditions
  • Privacy Statement
Looking for more? Sign up today!

    Contact Us
    jom@pnpco.com
    Copyright 2023-2025 Weston Medical Publishing, LLC - All Rights Reserved
    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    Privacy Statement


    Privacy and User Data Policy

    GDPR Update:

    The data collected from registered and non-registered users of this journal falls within the scope of the standard functioning of peer-reviewed journals. It includes information that makes communication possible for the editorial process; it is used to informs readers about the authorship and editing of content; it enables collecting aggregated data on readership behaviors, as well as tracking geopolitical and social elements of scholarly communication.

    This journal’s editorial team uses this data to guide its work in publishing and improving this journal. Data that will assist in developing this publishing platform may be shared with its developer Public Knowledge Project in an anonymized and aggregated form, with appropriate exceptions such as article metrics. The data will not be sold by this journal or PKP nor will it be used for purposes other than those stated here. The authors published in this journal are responsible for the human subject data that figures in the research reported here.

    Those involved in editing this journal seek to be compliant with industry standards for data privacy, including the European Union’s General Data Protection Regulation (GDPR) provision for “data subject rights” that include (a) breach notification; (b) right of access; (c) the right to be forgotten; (d) data portability; and (e) privacy by design. The GDPR also allows for the recognition of “the public interest in the availability of the data,” which has a particular saliency for those involved in maintaining, with the greatest integrity possible, the public record of scholarly publishing.

    Requests per item (a) through (e) above should be sent to the journal's mailbox, jom(at)pnpco.com

    The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

    What Data does this Website Process?

    The system, based the PKP Open Journal System applications, process personal data as a fundamental part of their operations. Most data is only provided by consent, ie. through manual user registration, though some visitation data (eg. cookies, usage logs) may also be recorded.

    User Registration Data

    When a visitor creates a user account in a PKP application, the following personal information is processed and stored (with some minor variation between OMP and OJS, and from version to version):

    ●   Salutation

    ●   First name*

    ●   Middle name

    ●   Last name*

    ●   Suffix

    ●   Username

    ●   Gender

    ●   Password (encrypted)

    ●   Email address*

    ●   ORCiD ID

    ●   Website

    ●   Mailing Address

    ●   Country

    ●   Phone

    ●   Fax

    ●   Affiliation

    ●   Biography

    ●   Registration date

    ●   Last login date

    ●   Locales

    ●   Reviewing interests

    ●   Role registrations (author, reader, and/or reviewer)

    Only the username, first name, last name, email and password fields are required.

    Storage

    This information is stored in the application database. Only the user password

    is encrypted.

    Availability and Access

    This information is available to the user via their User Profile (and, with the exception of the username and dates, can be edited). System administrators, journal managers, and editors can also access and edit this data (except the username and dates) via the application back end. The data can be downloaded by journal managers in XML format. The data is not otherwise publicly available.

    Erasure

    This data can be erased by the journal manager using the Merge Users tool, without affecting any editorial records. The erasure is subject to the considerations raised in the section “Scholarly Publishing, Data Privacy, and the Public Interest”, above.

    Contributor Metadata Information

    When a manuscript is submitted to a PKP application, contributor information is included. Contributors can be authors, translators, volume editors, and so on. This information is stored as submission metadata and is provided as part of any published manuscript record. The following contributor information is collected:

    ●   Salutation

    ●   First name*

    ●   Middle name

    ●   Last name*

    ●   Email address*

    ●   Suffix

    ●   ORCiD ID

    ●   Website

    ●   Country*

    ●   Affiliation

    ●   Biography

    Only the first name, last name, email address and country fields are required.

    Storage

    This information is stored in the application database.

    Data Transfer

    We do not sell or transfer to third parties user information from this system.

    General Visitor Information

    PKP applications also collect general visitor usage data, including:

    ● Cookie information, to manage session history. Cookies are required to maintain a login session in PKP applications.

    ● Optionally, detailed usage log data, including: IP address; pages visited; date visited; and browser information, in application log files, as part of the Usage Statistics plugin. An anonymization option is available to privatize this information.

    ● Optionally, country, region and city information, in the metrics database. This data collection requires additional setup and is not enabled by default.

    Other data may be tracked, either on the server or via third parties:

    ● Script loads from CDN servers;

    ● IP address information (including date, browser, etc.) in web server logs (separate from application log files as part of the Usage Statistics plugin).

    Detailed instructions in limiting the amount of data you collect, and providing consent for the data you collect, can be found below.

    Storage

    ● Cookies: A cookie (usually titled “OJSSID” or “OMPSID”) is created when first visiting a PKP application and is stored on the visitor’s computer. It is only used to store a session ID, and to facilitate logins. (If the visitor blocks cookies, OJS will still work properly, though they will not be able to log in.)

    ● Usage Statistics log files: As part of the usage statistics framework and plugin, OJS may store detailed application log files in the submission files directory (configured as the files_dir parameter in the OJS config.inc.php file), in a “usageStats” directory.

    ● Geographical data: Filtered usage data, including possibly geographic data, is also stored in the OJS database, in a “metrics” table.

    Availability and Access

    ● Cookies: These are available via the visitor’s browser settings.

    ● Usage Statistics log files: Only individuals with server file access can access application log files.

    ● Geographical data: Journal Managers can access filtered usage data by using the OJS usage report plugins.

    Erasure

    ● Cookies: These can be deleted via the visitor browser.

    ● Usage Statistics log files: These can be erased by system administrators with file access.

    ● Geographical data: This can only be erased by deleting records from the database directly, which also typically requires system administrator access.

    Portions of this privacy statement are copyright by Simon Fraiser University Licensed wth CC4.0-BY.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT